Association of Bartter's syndrome with vasculitis.
Deliyska
B
B
Clinical Center of Nephrology and Department of Pathology, Medical University, Sofia, Bulgaria.
Lazarov
V
V
Minkova
V
V
Nikolov
D
D
Tishkov
I
I
D000328:Adult; D001477:Bartter Syndrome / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010956:Plasmapheresis; D017419:Potassium, Dietary / Q000008:administration & dosage; D011241:Prednisone / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014657:Vasculitis / Q000150:complications* / Q000628:therapy
D000451:Mineralocorticoid Receptor Antagonists; D017419:Potassium, Dietary; D013148:Spironolactone; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone